Federation Francophone De Cancerologie Digestive

This study tested whether adding a drug called ipilimumab to the standard two-drug combination (atezolizumab and bevacizumab) works better for people with advanced liver cancer that cannot be treated with surgery. It involved 229 patients and measured how long patients lived and …